Chronic macrocheilia: a clinico-etiological series of 47 cases.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
27
04
2021
received:
15
01
2021
accepted:
03
05
2021
pubmed:
4
6
2021
medline:
17
11
2021
entrez:
3
6
2021
Statut:
ppublish
Résumé
Macrocheilia is an inflammatory disfiguring condition responsible for the swelling of the lips. This multi-etiological entity represents a diagnostic and therapeutic challenge. Published data on macrocheilia is scarce, often limited to granulomatous cheilitis. We conducted a retrospective study, including all patients presenting with chronic macrocheilia (CM) for nineteen years. CM was defined as a persistent enlargement of one or both lips for at least eight weeks. Both descriptive and analytical analyses were performed. Of the 47 patients identified, 20 (43%) had cutaneous leishmaniasis, 10 (21%) had Miescher's cheilitis, five (11%) had Melkersson-Rosenthal syndrome, five (11%) had sarcoidosis, one (2%) had lepromatous leprosy, one (2%) had systemic amyloidosis, and one (2%) had Crohn's disease. In four cases, the CM was unlabeled. Ulcerations were significantly associated with leishmaniasis (P < 0.05). Histological study showed a granulomatous infiltrate in 72% of cases. Medical treatment was adapted to the etiology of CM. Surgery was performed in two cases. Improvement of CM secondary to leishmaniasis was seen in all cases. In patients with idiopathic orofacial granulomatosis, partial improvement was noted in four cases and a total improvement in one case. Recurrences were noted in three cases after complete regression. Macrocheilia is a rare and disfiguring condition that requires an etiological investigation, considering that it can reveal a serious underlying systemic disease. We identified several factors that could help recognize the cause of CM, including age, history of intermittent swelling, the extent of lip enlargement, the existence of ulceration, and systemic symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Macrocheilia is an inflammatory disfiguring condition responsible for the swelling of the lips. This multi-etiological entity represents a diagnostic and therapeutic challenge. Published data on macrocheilia is scarce, often limited to granulomatous cheilitis.
METHODS
METHODS
We conducted a retrospective study, including all patients presenting with chronic macrocheilia (CM) for nineteen years. CM was defined as a persistent enlargement of one or both lips for at least eight weeks. Both descriptive and analytical analyses were performed.
RESULTS
RESULTS
Of the 47 patients identified, 20 (43%) had cutaneous leishmaniasis, 10 (21%) had Miescher's cheilitis, five (11%) had Melkersson-Rosenthal syndrome, five (11%) had sarcoidosis, one (2%) had lepromatous leprosy, one (2%) had systemic amyloidosis, and one (2%) had Crohn's disease. In four cases, the CM was unlabeled. Ulcerations were significantly associated with leishmaniasis (P < 0.05). Histological study showed a granulomatous infiltrate in 72% of cases. Medical treatment was adapted to the etiology of CM. Surgery was performed in two cases. Improvement of CM secondary to leishmaniasis was seen in all cases. In patients with idiopathic orofacial granulomatosis, partial improvement was noted in four cases and a total improvement in one case. Recurrences were noted in three cases after complete regression.
CONCLUSIONS
CONCLUSIONS
Macrocheilia is a rare and disfiguring condition that requires an etiological investigation, considering that it can reveal a serious underlying systemic disease. We identified several factors that could help recognize the cause of CM, including age, history of intermittent swelling, the extent of lip enlargement, the existence of ulceration, and systemic symptoms.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1497-1503Informations de copyright
© 2021 the International Society of Dermatology.
Références
Burton JL, Scully C, Champion RH, et␣al. Textbook of Dermatology. Oxford: Blackwell Science, 1998. The lips: 3139-3141.
Handa S, Saraswat A, Radotra BD, et␣al. Chronic macrocheilia: a clinico-pathological study of 28 patients. Clin Exp Dermatol 2003; 28: 245-250.
Miest R, Bruce A, Rogers RS 3rd. Orofacial granulomatosis. Clin Dermatol 2016; 34: 505-513.
Galadari H, Krompouzos G, Kassir M, et␣al. Complication of soft tissue fillers: prevention and management review. J Drugs Dermatol 2020; 19: 829-832.
Plantier F. Chéilite de Miescher. Ann Dermatol Venereol 2016; 143: 486-489.
Allen CM, Camisa C, Hamzeh S, et␣al. Cheilitis granulomatosa: report of six cases and review of literature. J Am Acad Dermatol 1990; 23: 444-450.
Zimmer WM, Rogers RS, Reeve CM, et␣al. Orofacial manifestations of Melkersson Rosenthal syndrome. Oral Surg Oral Med Oral Pathol 1992; 74: 610-619.
Bahrami F, Späth GF, Rafati S. Old world cutaneous leishmaniasis challenges in Morocco, Algeria, Tunisia and Iran (MATI): a collaborative attempt to combat the disease. Expert Rev Vaccines 2017; 16: 415-417.
Hammami-Ghorbel H, Ben Abda I, Badri T, et␣al. Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia. J Eur Acad Dermatol Venereol 2015; 29: 1212-1215.
Benmously R, Ben Hmida M, Hammami H, et␣al. La leishmaniose muqueuse en Tunisie: étude de 12 cas. Ann Dermatol Venereol 2011; 138: A248-A249.
Zaraa I, Ishak F, Kort R, et␣al. Childhood and adult cutaneous leishmaniasis in Tunisia. Int J Dermatol 2010; 49: 790-793.
Kevric I, Cappel MA, Keeling JH. New world and old world Leishmania infections: a practical review. Dermatol Clin 2015; 33: 579-593.
Campbell H, Escudier M, Patel P, et␣al. Distinguishing orofacial granulomatosis from Crohn's disease: two separate disease entities? Inflamm Bowel Dis 2011; 17: 2109-2115.
Dodi I, Verri R, Brevi B, et␣al. A monosymptomatic Melkersson-Rosenthal syndrome in an 8-year old boy. Acta Biomed 2006; 77: 20-23.
van der Waal R, Schulten E, van de Scheur MR, et␣al. Cheilitis granulomatosa. J Eur Acad Dermatol Venereol 2001; 15: 519-523.
Luscher E. Syndrome von Melkersson-Rosenthal. Schweiz Med Wochenschr 1949; 79: 1-3.
Hornstein OP. Melkersson-Rosenthal syndrome: a challenge for dermatologists to participate in the field of oral medicine. J Dermatol 1997; 24: 281-296.
van der Waal RIF, Schulten EAJM, van der Meij EH, et␣al. Cheilitis granulomatosa: overview of 13 patients with long-term follow-up-results of management. Int J Dermatol 2002; 41: 225-229.
Worsaae N, Christensen KC, Schiodt M, et␣al. Melkersson-Rosenthal syndrome and cheilitis granulomatosa. A clinicopathological study of thirty-three patients with special reference to their oral lesions. Oral Surg Oral Med Oral Pathol 1982; 54: 404-413.
Jaouen F, Tessier MH, Vaillant L, et␣al. Response to systemic therapies in granulomatous cheilitis: retrospective multicenter series of 61 patients. J Am Acad Dermatol 2021; S0190-9622(21)00407-2. [published online ahead of print, 2021 Feb 20].
Bacci C, Valente ML. Successful treatment of cheilitis granulomatosa with intralesional injection of triamcinolone. J Eur Acad Dermatol Venereol 2010; 24: 363-364.
Sobjanek M, Michajłowski I, Żelazny I, et␣al. What is the most effective treatment of cheilitis granulomatosa in Melkersson-Rosenthal syndrome? J Eur Acad Dermatol Venereol 2010; 24: 364-365.
Sobjanek M, Włodarkiewicz A, Zelazny I, et␣al. Successful treatment of Melkersson-Rosenthal syndrome with dapsone and triamcinolone injections. J Eur Acad Dermatol Venereol 2008; 22: 1028-1029.
Allen CM, Camisa C, Hamzeh S, et␣al. Cheilitis granulomatosa: report of six cases and review of the literature. J Am Acad Dermatol 1990; 23: 444-450.
Pigozzi B, Fortina AB, Peserico A. Successful treatment of Melkersson-Rosenthal syndrome with lymecycline. Eur J Dermatol 2004; 14: 166-167.
Coskun B, Saral Y, Cicek D, et␣al. Treatment and follow-up of persistent granulomatous cheilitis with intralesional steroid and metronidazole. J Dermatolog Treat 2004; 15: 333-335.
Ishiguro E, Hatamochi A, Hamasaki Y, et␣al. Successful treatment of granulomatous cheilitis with roxithromycin. J Dermatol 2008; 35: 598-600.
Thomas P, Walchner M, Ghoreschi K, et␣al. Successful treatment of granulomatous cheilitis with thalidomide. Arch Dermatol 2003; 139: 136-138.
Barry O, Barry J, Langan S, et␣al. Treatment of granulomatous cheilitis with infliximab. Arch Dermatol 2005; 141: 1080-1082.
Kruselösler B, Presser D, Metze D, et␣al. Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Arch Dermatol 2005; 141: 1085-1091.
Kalmar JR. Crohn's disease: orofacial considerations and disease pathogenesis. Periodontol 2000 1994; 6: 101-115.
Bourgeois-Droin C, Havard S, Granier F, et␣al. Granulomatous cheilitis in two children with sarcoidosis. J Am Acad Dermatol 1993; 29: 822-824.
Singh G, Nagaraja PS. Leprosy presenting as macrocheilia. Indian J Lepr 1999; 71: 341-342.
High AS, Lansley CV. Labial and gingival enlargement in leprosy. Br Dent J 1988; 165: 371-372.